Kampman, Kyle M.

A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 391

The Status of Disulfiram: A Half of a Century Later

Suh, J. J., Pettinati, H. M., Kampman, K. M., & O'Brien, C. P. (2006) · Journal of Clinical Psychopharmacology

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 382

Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence: A Randomized, Placebo-Controlled Trial

Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H. D., Kampman, K., Dackis, C., & O’Brien, C. P. (2006) · Archives of General Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 348

A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence

Litten, R. Z., Ryan, M. L., Fertig, J. B., Falk, D. E., Johnson, B., Dunn, K. E., Green, A. I., Pettinati, H. M., Ciraulo, D. A., Sarid-Segal, O., et al. (2013) · Journal of Addiction Medicine

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 287

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Haight, B. R., Learned, S. M., Laffont, C. M., Fudala, P. J., Zhao, Y., Garofalo, A. S., Greenwald, M. K., Nadipelli, V. R., Ling, W., Heidbreder, C., et al. (2019) · The Lancet

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 285

Reliability and validity of the cocaine selective severity assessment

Kampman, K. M., Volpicelli, J. R., Mcginnis, D. E., Alterman, A. I., Weinrieb, R. M., D’Angelo, L., & Epperson, L. E. (1998) · Addictive Behaviors

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 272

The treatment of cocaine use disorder

Kampman, K. M. (2019) · Science Advances

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 250

A double-blind, placebo-controlled trial of modafinil for cocaine dependence

Dackis, C. A., Kampman, K. M., Lynch, K. G., Plebani, J. G., Pettinati, H. M., Sparkman, T., & O'Brien, C. P. (2012) · Journal of Substance Abuse Treatment

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 187

Comparison of Treatments for Cocaine Use Disorder Among Adults: A Systematic Review and Meta-analysis

Bentzley, B. S., Han, S. S., Neuner, S., Humphreys, K., Kampman, K. M., & Halpern, C. H. (2021) · JAMA Network Open

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 161

A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence

Kampman, K. M., Pettinati, H. M., Lynch, K. G., Spratt, K., Wierzbicki, M. R., & O’Brien, C. P. (2013) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 115

A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence

Pettinati, H. M., Kampman, K. M., Lynch, K. G., Xie, H., Dackis, C., Rabinowitz, A. R., & O′Brien, C. P. (2008) · Addictive Behaviors

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 95

Executive summary of the focused update of the ASAM national practice guideline for the treatment of opioid use disorder

Crotty, K., Freedman, K. I., & Kampman, K. M. (2020) · Journal of Addiction Medicine

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 95

Gabapentin enacarbil extended-release for alcohol use disorder: a randomized, double-blind, placebo-controlled, multisite trial assessing efficacy and safety

Falk, D. E., Ryan, M. L., Fertig, J. B., Devine, E. G., Cruz, R., Brown, E. S., Burns, H., Salloum, I. M., Newport, D. J., Mendelson, J., et al. (2019) · Alcoholism: Clinical and Experimental Research

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 89

A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence

for the National Institute on Alcohol Abuse and Alcoholism Clinical Investigations Group (NCIG) Study Group, Ryan, M. L., Falk, D. E., Fertig, J. B., Rendenbach-Mueller, B., Katz, D. A., Tracy, K. A., Strain, E. C., Dunn, K. E., Kampman, K., et al. (2017) · Neuropsychopharmacology

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 72

Insomnia in alcohol dependent subjects is associated with greater psychosocial problem severity

Chaudhary, N. S., Kampman, K. M., Kranzler, H. R., Grandner, M. A., Debbarma, S., & Chakravorty, S. (2015) · Addictive Behaviors

Sleep and related disordersSubstance Abuse Treatment and Outcomes

Cited by 60

Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction

Clarke, T. ‐., Ambrose‐Lanci, L., Ferraro, T. N., Berrettini, W. H., Kampman, K. M., Dackis, C. A., Pettinati, H. M., O’Brien, C. P., Oslin, D. W., & Lohoff, F. W. (2012) · Genes, Brain and Behavior

Neurotransmitter Receptor Influence on BehaviorGenetic Associations and Epidemiology

Cited by 55

Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users

Levin, F. R., Mariani, J. J., Pavlicova, M., Choi, C. J., Mahony, A. L., Brooks, D. J., Bisaga, A., Dakwar, E., Carpenter, K. M., Naqvi, N., et al. (2020) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 54